Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Higher tiers mean higher copays
Of the 1,267 adult participants with obesity who took part in the trial, the mean weight loss percentages were as follows by 56 weeks: For those who took a placebo: 2.1% For those who took a 3.75/23 mg dose: 6.7% For those who took a 15/92 mg dose: 14.4% Participants in both clinical trials involved diet and exercise as part of their treatment plan
Keep it light and skip on dose-increase days
The focus of this study was a specific molecular mechanism: how obesity-driven metabolic changes affect a transcription factor called YAP, and how that, in turn, drives chemotherapy resistance in TNBC
Targets multiple receptors (GLP-1, GIP, and glucagon) for comprehensive metabolic impact
Lantus also participates in our Insulin Val you Savings Plan where patients without any insurance or commercially insured patients paying cash pay $35 for a monthly supply of one or a combination of Sanofi Insulins
US$ 20.24
US$ 25.72
US$ 28.15
US$ 26.01
US$ 22.85
